[HTML][HTML] The NLRP3 inflammasome: an overview of mechanisms of activation and regulation

N Kelley, D Jeltema, Y Duan, Y He - International journal of molecular …, 2019 - mdpi.com
The NLRP3 inflammasome is a critical component of the innate immune system that
mediates caspase-1 activation and the secretion of proinflammatory cytokines IL-1β/IL-18 in …

[HTML][HTML] Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors

Y Yang, H Wang, M Kouadir, H Song, F Shi - Cell death & disease, 2019 - nature.com
The NLRP3 inflammasome is a multimeric protein complex that initiates an inflammatory
form of cell death and triggers the release of proinflammatory cytokines IL-1β and IL-18. The …

Inflammasomes in neuroinflammatory and neurodegenerative diseases

S Voet, S Srinivasan, M Lamkanfi… - EMBO molecular …, 2019 - embopress.org
Neuroinflammation and neurodegeneration often result from the aberrant deposition of
aggregated host proteins, including amyloid‐β, α‐synuclein, and prions, that can activate …

[HTML][HTML] Pharmacological inhibitors of the NLRP3 inflammasome

A Zahid, B Li, AJK Kombe, T Jin, J Tao - Frontiers in immunology, 2019 - frontiersin.org
Inflammasomes play a crucial role in innate immunity by serving as signaling platforms
which deal with a plethora of pathogenic products and cellular products associated with …

The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease

S Wang, YH Yuan, NH Chen, HB Wang - International …, 2019 - Elsevier
Parkinson's disease (PD) is a typical neurodegenerative disease and the pathological
feature of which is the death of dopamine neurons in the substantia nigra region. At present …

[HTML][HTML] Modulatory mechanisms of the NLRP3 inflammasomes in diabetes

S Ding, S Xu, Y Ma, G Liu, H Jang, J Fang - Biomolecules, 2019 - mdpi.com
The inflammasome is a multiprotein complex that acts to enhance inflammatory responses
by promoting the production and secretion of key cytokines. The best-known inflammasome …

Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease

BS Thawkar, G Kaur - Journal of neuroimmunology, 2019 - Elsevier
Microglial activation is a distinguished attribute in many neurodegenerative diseases of
aging. Compelling evidence suggests that neuroinflammation stimulated by microglia, the …

[HTML][HTML] A novel small molecular NLRP3 inflammasome inhibitor alleviates neuroinflammatory response following traumatic brain injury

R Kuwar, A Rolfe, L Di, H Xu, L He, Y Jiang… - Journal of …, 2019 - Springer
Background Neuroinflammation is an essential player in many neurological diseases
including traumatic brain injury (TBI). Recent studies have identified that inflammasome …

[HTML][HTML] Drug development for Alzheimer's disease: microglia induced neuroinflammation as a target?

Y Dong, X Li, J Cheng, L Hou - International Journal of Molecular …, 2019 - mdpi.com
Alzheimer's disease (AD) is one of the most common causes of dementia. Its pathogenesis
is characterized by the aggregation of the amyloid-β (Aβ) protein in senile plaques and the …

Sustained release of bioactive hydrogen by Pd hydride nanoparticles overcomes Alzheimer's disease

L Zhang, P Zhao, C Yue, Z Jin, Q Liu, X Du, Q He - Biomaterials, 2019 - Elsevier
Oxidative stress-induced mitochondrial dysfunction plays an important role in the
pathogenesis of Alzheimer's disease (AD). Hydrogen molecule, a special antioxidant, can …